FeverAll’s acetaminophen suppositories hit Target shelves
FeverAll is expanding the distribution of its infant-focused acetaminophen suppositories. The Taro Pharmaceuticals brand has expanded its distribution nationwide to Target stores and Target.com.
FeverAll’s acetaminophen suppositories are meant to temporarily reduce fever and relieve minor aches, pain and headaches for infants ages six months to 36 months old. The delivery method helps ensure dosing accuracy, removing the need for measuring, and is the recommended dosing method for children who can’t take liquid acetaminophen, the company said.
“The FeverAll brand’s continued growth at current retailers, combined with the ongoing need for a unique product like this for parents and their children’s healthcare providers, has helped drive our new Target distribution,” said Phil Tucker, director of OTC sales at Taro Pharmaceuticals U.S.A.
Tucker said the product is free of high fructose corn syrup, parabens, artificial colors, preservatives and alcohol.
FeverAll’s acetaminophen suppositories are meant to temporarily reduce fever and relieve minor aches, pain and headaches for infants ages six months to 36 months old. The delivery method helps ensure dosing accuracy, removing the need for measuring, and is the recommended dosing method for children who can’t take liquid acetaminophen, the company said.
“The FeverAll brand’s continued growth at current retailers, combined with the ongoing need for a unique product like this for parents and their children’s healthcare providers, has helped drive our new Target distribution,” said Phil Tucker, director of OTC sales at Taro Pharmaceuticals U.S.A.
Tucker said the product is free of high fructose corn syrup, parabens, artificial colors, preservatives and alcohol.